Stat3 mediates a complex spectrum of cellular responses, including inflammation, cell proliferation, and apoptosis. Although evidence exists in support of a positive role for Stat3 in cancer, its role has remained somewhat controversial because of insufficient study of how its genetic deletion may affect carcinogenesis in various tissues. In this study, we show using epithelium-specific knockout mice (Stat3 D/D ) that Stat3 blunts rather than supports antitumor immunity in carcinogen-induced lung tumorigenesis. Although Stat3
Introduction
The importance of inflammatory mediators and cells in the tumor microenvironment has recently become the focus of much attention. In some types of cancer, inflammatory conditions initiate or promote oncogenic transformation, whereas in other types of cancer, genetic and epigenetic changes in malignant cells conversely generate an inflammatory microenvironment that further supports tumor progression (1) . In addition, cumulative experimental findings indicate that the immune system controls tumor incidence and growth (2) . For instance, in colon and ovarian cancers, the presence of infiltrating CTLs or natural killer (NK) cells is associated with a better prognosis (3, 4) . In addition, innate immune cells, such as macrophages, NK cells and dendritic cells, can destroy tumor cells when appropriately activated. T cells from the adaptive arm of the immune system can also attack tumors when activated in a type 1 helper T (Th1) immunologic milieu (5, 6) . By contrast, tumor-associated macrophages have been shown to promote cancers, partly through their ability to secrete angiogenic, metastatic, and growth factors (1) . Another related myeloid lineage, myeloid-derived suppressor cells, which are increased in cancers, not only suppress antitumor immunity but also directly contribute to tumor growth (7) . Therefore, it remains controversial how inflammation and immunity influence tumorigenesis.
Stat3 mediates signals for interleukin-6 (IL-6), IL-11, oncostatin M, leukemia inhibitory factor, and ciliary neurotropic factor, and activates the transcription of various target genes. Although Stat3 was originally identified as an inducible DNAbinding protein that binds an IL-6-responsive element within the promoter of hepatic acute phase protein genes, Stat3 is expressed in a variety of cells and tissues and exerts pleiotropic functions. Because a Stat3 deletion leads to embryonic lethality in mice (8) , the physiologic and pathologic significance of Stat3 in adult organs has been investigated using conditional knockout animals generated using the Cre/loxP recombination system (9) . These studies revealed that Stat3 exerts a variety of biologic functions, including cell growth, antiapoptosis, and cell motility, depending on the cell types and stimuli. With regard to the role of Stat3 in promoting or inhibiting cancer, Stat3 has been implicated in the survival and proliferation of various cancer cells by upregulating the expression of various genes, including Bcl-xL (10), Mcl-1 (11), cyclin D1 (12) , and cMyc (13) . In addition to these cell autonomous effects, Stat3 has been shown to have cancer-promoting properties through "bystander" effects, such as stimulating angiogenesis and regulating inflammatory and immune responses in tumor microenvironments (14) . On the basis of these in vitro studies with cancer cell lines, in vivo tumorigenesis models using tissuespecific knockout mice have revealed that Stat3 promotes tumorigenesis in the colon (15, 16) , stomach (17) , and pancreas (18, 19) by enhancing tumor-associated inflammation and tumor proliferation. In fact, the association between inflammation and tumorigenesis is very strong in these organs. However, no firm causal relationships with inflammation or infection have been established for lung tumorigenesis (20) (21) (22) . In addition, the role of Stat3 in carcinogen-induced lung tumorigenesis has not been examined.
In this study, we used urethane-induced lung tumorigenesis models and found that tumorigenesis was significantly reduced in Stat3 
Materials and Methods

Animal experiments
Stat3 D/D mice were generated as previously described (23, 24) . Briefly, the human surfactant protein (hSP)-C promoter was used to express the reverse tetracycline transactivator (rtTA).
In the presence of doxycycline, rtTA binds to the (tetO) 7 promoter, activating transcription of the Cre recombinase. group) were sacrificed with a lethal intraperitoneal phenobarbital injection 6 months after urethane treatment. The trachea was cannulated and the lungs were lavaged 3 times with 1 mL of saline. The volumes of recovered bronchoalveolar lavage (BAL) fluid from mice in both groups were similar. After centrifugation, BAL cells were counted using a hemocytometer to determine total BAL cell count. Differential cell counts based on cell morphology were carried out after cytospin followed by May-Giemsa staining to classify the infiltrating cells as monocytes/macrophages, lymphocytes, neutrophils, or eosinophils. Data were analyzed using JMP version 9.0.2 (SAS Institute). The normality of distribution was examined by visually inspecting Q-Q plots. Two groups (Stat3 flox/flox vs. Stat3 D/D ) were compared using the ANOVA model, which included the following factors: the mouse groups, TV, and the interaction between the groups and TV. A 2-sided P value less than or equal to 0.05 was considered significant. A nonparametric analysis was also conducted to confirm the robustness of the ANOVA analysis results.
Immunohistochemistry
Lungs were inflation fixed (25 cmH 2 O) with 4% paraformaldehyde/PBS for 1 minute, immersed in the same fixative for 18 hours at 4 C and then processed according to standard methods for paraffin-embedded blocks. Immunohistochemistry (IHC) was carried out on 5-mm thick sections. The following primary antibodies were used: Clara cell secretory protein (CCSP; 1:1,500, rabbit polyclonal; Seven Hills Bioreagents), prosurfactant protein (SP)-C (1:2,000, rabbit polyclonal; Seven Hills Bioreagents), phospho-Stat3 (Tyr705; rabbit polyclonal; Cell Signaling Technology), VEGF receptor (VEGFR)-2 (1:300, rabbit IgG; Cell Signaling Technology), phospho-histone-3 (PH-3; 1:500, rabbit polyclonal; Santa Cruz Biotech), cleaved caspase-3 (1:1,600, rabbit polyclonal; Cell Signaling Technology), and Bcl-xL (1:300, rabbit polyclonal; Cell Signaling).
Cell lines
A549 was obtained from the Japanese Collection of Research Bioresources. KHYG-1 was obtained from Health Science Research Resource Bank. HCC827 and H3255 were kindly gifted from Pasi A. J€ anne (Dana-Farber Cancer Institute/Department of Medical Oncology, Boston, MA). HFL-1 was obtained from Riken BioResource Center. NCI-H292, 3T3, H441, and THP-1 were purchased from the American Type Culture Collection.
Western blot analysis and ELISA
Lung tissue was snap-frozen in liquid nitrogen. Frozen tissue was broken into pieces using a mortar and lysed in 5 mL of T-PER Tissue Protein Extraction Reagent (Pierce). After centrifuging at 1,000 Â g for 5 minutes, the supernatants were stored at À80 C. Western blot analysis was done using 20 mg of protein and the following primary antibodies: phospho-histone-3 (PH-3; 1:500, rabbit polyclonal; Santa Cruz Biotech), VEGFR-2 (1:250, rabbit IgG; Cell Signaling Technology), phospho-Stat3 (1:1,000, rabbit polyclonal; Cell Signaling Technology), mouse MHC class I (ER-HR52; 1:200, rat monoclonal IgG2a; Santa Cruz), human MHC class I (W6/32; 1:400, mouse monoclonal IgG2a; Santa Cruz), and actin [1:1,000, horseradish peroxidase (HRP)-conjugated goat polyclonal; Santa Cruz]. A goat anti-rabbit IgG (HþL)-HRP conjugated (BioRad) or HRPgoat anti-rat IgG (HþL; Invitrogen) antibody was used as the secondary antibody. The levels of IFN-g, TNF-a, and IL-6 in the supernatants were determined using quantitative murine sandwich ELISA kits (R&D Systems Inc.) and normalized to the total lung tumor volume.
Microarray analysis
Lung tumors were microdissected and pooled. RNA was extracted with RNAiso Plus (Takara Bio) and purified with an RNeasy Mini Kit (Qiagen). The RNA quality and quantity were analyzed using an Agilent 2100 Bioanalyzer (Agilent Technologies) and NanoDrop ND-1000 (Thermo Fisher Scientific), respectively. Gene expression was analyzed using GeneChips mouse genome 430 2.0 array (Affymetrix) according to the manufacturer's protocol. Arrays were scanned on a GeneChip scanner 3000 (Affymetrix).
Construction of protein-protein interaction networks and functional analysis of the differentially expressed genes by characterization of enriched biologic associations
Protein-protein interactions (PPI) for genes that showed increased or decreased expression in the microarray studies were retrieved from the BioGRID (25) and iRefIndex 8.0 (26) databases using the TargetMine data warehouse (27) . Biologic pathway data from KEGG (28) were used to assign functional annotations to the genes in the upregulated and downregulated networks. The overexpression of specific KEGG pathway associations within each network was estimated by carrying out the hypergeometric test within TargetMine. The inferred P values were further adjusted for multiple test corrections to control for the false discovery rate using the Benjamini and Hochberg method (29) , and the pathway annotations were considered significant if P value was less than or equal to 0.05.
Knockdown experiment with siRNA
Cells were transfected with either siRNA against human Stat3 or control cocktail RNAs (B-Bridge International), using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's protocol. After a 48-hour incubation, the cells were replated in serum-containing medium (5 Â 10 5 /mL) and cultured for another 30 hours. Protein and RNA expression was analyzed by Western blot and TaqMan real-time reverse transcriptase PCR (Applied Biosystems), respectively. The concentrations of CCL5 and CXCL10 in the culture supernatants were determined using quantitative murine sandwich ELISA kit (R&D).
In vitro migration assay
The migration of monocytes (THP-1 cells) was measured by a modified Boyden chamber migration assay. THP-1 cells were loaded into Transwell inserts (5-mm porous membrane; Corning). The culture supernatants of non-small cell lung cancer (NSCLC) cell lines transfected with Stat3 siRNA or control siRNA were placed in the lower chamber. Cells on the upper side of the membrane were removed after 4 hours and the number of migratory cells was determined by Guava ViaCount assays (Millipore).
Cytotoxic assay
Susceptibility to NK cell-mediated cytotoxicity was measured by a conventional 4-hour 51 Cr-release assay as previously described (30) . Briefly, the target cells, an NSCLC cell line (H3255 and H441) that was transfected with Stat3 or control siRNA, were labeled with 51 Cr and mixed with effector cells, KHYG-1 cells, at different effector/target (E/T) ratios. After a 4-hour incubation, the supernatant was collected for liquid scintillation counting. Spontaneous 51 Cr-release was measured in target cells incubated without effector cells, and the maximal release was measured by treating the target cells with 5% Triton X-100. The percent specific lysis was determined using the following formula: % specific lysis ¼ 100 Â (experimental release À spontaneous release)/(maximum release À spontaneous release).
Statistical analysis
All statistical analyses were done using JMP version 9.0.2 (SAS). Data are expressed as the means AE SE. The differences between the 2 groups were evaluated using 2-sided Student t test or ANOVA. P values less than 0.05 were considered statistically significant. (Fig. 1C, Supplementary Fig. S1 ). IHC for CCSP, a Clara cell marker, and pro-SP-C, an alveolar type II epithelial cell marker, revealed that the tumor cells were CCSPnegative and pro-SP-C-positive, indicating that they developed from alveolar type II epithelial cells (Fig. 1C) Fig. 2A and B) . With regard to vascular development, immunohistochemical analysis for VEGFR-2 showed that the expression of VEGFR-2 was specifically stained in the vascular endothelial cells but not in tumor cells, in which there were no difference between Stat3 D/D mice and Stat3 flox/flox mice ( Fig. 2A) . In addition, we did not see significant differences in the levels of VEGFR-2 and VEGF in the lung homogenates between Stat3 D/D mice and Stat3 flox/flox mice ( Fig. 2B and C) . These findings unexpectedly showed that Stat3 in tumor cells has a minimal effect on mitosis, apoptosis, and angiogenesis in this model.
Results
Urethane-induced lung tumorigenesis was inhibited in
Tumor-associated inflammation was augmented in
It is well known that inflammation in the tumor microenvironment acts to either promote or inhibit tumors depending on the tissue type (1). Thus, we next examined the effects of an epithelial cell-specific Stat3 deletion on tumor-associated inflammation in the lung and surprisingly found significantly more inflammatory cells surrounding tumors in Stat3 D/D mice compared with Stat3 flox/flox mice (Fig. 3A) . Therefore, we carried out BAL to count inflammatory leukocytes in the lung. The number of inflammatory cells, including macrophages, lymphocytes, and neutrophils, recovered in the BAL fluid correlated with the TV, suggesting that inflammation correlated with tumor growth. Indeed, the ratios of inflammatory cell numbers to TV were significantly higher in Stat3 D/D mice compared with Stat3 flox/flox mice (Fig. 3B) . The relative concentrations of antitumor inflammatory mediators, such as IFN-g, TNF-a, and IL-6, to TV were also increased in the lungs of Stat3 D/D mice compared with Stat3 flox/flox mice (Fig. 3C ). Taken together Tables S1 and S2) . Because most genes function in association with other genes and gene products, to further understand the biologic significance of the different gene expression levels, we retrieved the PPIs for the upregulated and downregulated genes and inferred PPI networks using TargetMine. Next, we investigated the upregulated and downregulated gene expression cum PPI networks (comprising 396 and 490 genes, respectively) for the enrichment of specific KEGG pathway associations (Supplementary Tables S3 and S4 ). We observed that deleting Stat3 in tumor cells led to a significant increase in genes associated with chemokine production (CCL2, CCL9, CCL12, CCL17, and CCL21c), which were mapped to the enriched KEGG pathway, "chemokine signaling pathway" (P ¼ 1.53 Â 10
À4
) and function in inflammatory immune responses (Fig. 4A) . Also, there was a significant decrease in genes involved in NK cell-related MHC class I expression (H2-D1, H2-K1, and H60a), which were mapped to the enriched KEGG pathway, "NK cell-mediated cytotoxicity" (P ¼ 8.46 Â 10
À6
) and are associated with the innate immune system (Fig. 4B) . In this context, we hypothesized that a Stat3 deletion promotes chemokine production and inhibits of MHC class I expression in tumor cells, leading to the upregulation of antitumor inflammatory responses.
Stat3 blockade increased chemokine expression in lung epithelial cell lines
To investigate whether Stat3 activation in tumor cells negatively regulates the expression of inflammatory mediators, we suppressed Stat3 expression in NSCLC cells using siRNA transfection. As reported previously, all NSCLC cells showed various degrees of constitutively activated Stat3 (Fig. 5A) . Introducing Stat3 siRNA significantly reduced Stat3 expression and upregulated the expression of chemokines, including CCL5 (RANTES) and CXCL10 (IP-10; Fig. 5B and C) . To confirm that the inflammatory factors that were produced by Stat3-suppressed NSCLC cell lines affect immunity, we carried out monocyte migration assays using cell culture supernatants from Stat3 siRNA-or control siRNA-transfected cells. As shown (Fig. 6A) . siRNA-mediated knockdown of Stat3 also decreased MHC class I expression in human lung cancer cell lines (Fig. 6B) . We finally tested whether Stat3 activation affects NK cell cytotoxic activities against tumor cells using 51
Cr-release assays with NSCLC cells (H3255 and H441) that were transfected with Stat3 siRNA. Stat3 knockdown increased the susceptibility of NSCLC cells to NK cell-mediated cytotoxicity (Fig. 6C) . These data indicated that Stat3 deletion in tumor cells downregulates the expression of the MHC class I to stimulate NK cell-mediated antitumor immunity.
Discussion
In this study, we investigated the role of Stat3 in carcinogen-induced lung tumorigenesis. Although Stat3 has been implicated in tumor growth, survival, and angiogenesis, we unexpectedly found that proliferation, apoptosis, and angiogenesis were not altered in Stat3 D/D lung tumors. Instead, we found that tumorigenesis was significantly reduced in Stat3 D/D mice, whereas tumor-associated inflammation was increased. We further carried out genome-wide mRNA profiling and found that Stat3 knockdown increased the expression of proinflammatory chemokines and decreased the expression of MHC class I. Thus, we provide evidence that Stat3 negatively regulates antitumor immunity during lung tumorigenesis.
Inhibitory roles of Stat3 in antitumor immunity during carcinogen-induced tumorigenesis
The role of Stat3 in inflammation-associated tumorigenesis has been extensively investigated in several organs, including the colon (15, 16) , stomach (17) , and pancreas (18, 19) . These studies indicated that Stat3 activation increases cancer-associated inflammation to promote proliferation and inhibit tumor cell apoptosis. In addition, it was reported that overexpressing a constitutively active Stat3 in airway epithelial cells in the lung promoted lung inflammation and tumor formation (31) . However, the roles of Stat3 in antitumor immunity during lung tumorigenesis have not been determined. In this study, we 
Negative regulation of chemokine production by Stat3
Here, we showed that Stat3 negatively regulates chemokine genes, including CCL5 and CXCL10, which play important roles in cancer-associated inflammation by attracting various subpopulations of immune effector cells (32, 33) . Consistent with this finding, Wang and colleagues reported that constitutively active Stat3 inhibits the production of multiple proinflammatory cytokines and chemokines in mouse cancer cell lines (34) .
Mice with a selective disruption of Stat3 in keratinocytes were reported to have defective wound healing associated with increased inflammatory infiltrates at the wound sites (35) . Thus, Stat3-mediated inhibition of proinflammatory factors affects not only the tumor microenvironment but also the site of physiologic wound healing.
With regard to the gene regulation by Stat3, Xu Y and colleagues previously reported the effects of a pulmonary epithelial cell-specific deletion of Stat3 using genome-wide mRNA expression profiling, in which they found that chemotaxis-related genes were significantly induced by a Stat3 deletion, and these authors also reported that STAT was the most significantly enriched cis-element in the promoter region of differentially expressed genes, suggesting that Stat3 directly controls the expression of these genes (36) . The pathway labels are mapped on the x-axis, whereas the y-axis represents the percentage of genes that mapped to a given KEGG pathway within the network and the mouse genome.
mediated by CD8 þ T cells. Indeed, Schreiber and colleagues reported that, although NK cells are important in the early elimination of tumors, the "dormant" tumor state is controlled by adaptive immunity mediated by CD8 þ T cells (37) . However, it has been reported that MHC class I-low tumor cells still evoke antitumor CD8 þ T-cell responses because NK cells, activated by MHC class I-low tumor cells, produce IFN-g that stimulates CD8 þ T cells (38, 39) . Thus, enhanced NK cell responses, together with increased chemokine production by tumor cells, may be primarily responsible for antitumor inflammation during urethane-induced tumors. It is also noteworthy that the efficacy of the antitumor cytotoxic activities of cytotoxic CD8 þ T cells (CTL) depends not only on the presentation of tumor antigens by the malignant cells but also on their susceptibility to CD8 þ T-cell-induced lysis. The hypoxic tumor microenvironment confers resistance to this CTL-mediated cytotoxic activity. Interestingly, it was recently reported that Stat3 and hypoxia-inducible factor (HIF)-1a are functionally linked to the alteration of NSCLC susceptibility to CTLmediated killing under hypoxic conditions (40) . In this context, Stat3 activation in tumor cells may affect tumor cell sensitivity to either NK cell-or CD8 þ T-cell-mediated cell killing.
With regard to the regulation of MHC class I expression by Stat3, there are several possibilities, which affect MHC class I expression during tumorigenesis, such as inflammatory cytokines, oncogenic transcriptional factors, and tumor-associated missing self-phenotypes. Further studies are necessary to clarify the mechanism of how Stat3 regulates the expression of MHC class I molecule.
Involvement of Stat3 in tumorigenesis and its clinical implication
Adenocarcinoma is the most common histologic type of lung cancer, accounting for almost half of all lung cancers. The relevant molecular events frequently observed in lung adenocarcinoma are KRAS mutations, epidermal growth factor receptor mutations, and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase translocations (41) . Stat3 is activated and responsible for the oncogenic phenotypes of adenocarcinoma caused by such molecular mutations or alterations (18, 19, 42, 43) . Thus, it is possible that Stat3 inhibition not only promotes antitumor immunity but also impairs oncogenic signals in adenocarcinoma. Indeed, several reports suggest that Stat3 activation is relevant to the progression of human NSCLC (44, 45) ; however, it may be difficult to determine the involvement of Stat3 activation in the in vivo tumorigenesis of NSCLC. We therefore think that our in vivo tumorigenesis model provides a clue to understand the involvement of Stat3 activation in NSCLC tumorigenesis. Collectively, our findings not only indicate a novel role for Stat3 in lung tumorigenesis but also provide a potential therapeutic target for lung cancers. 
